Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
The winding road of BioCryst Pharmaceuticals’ avoralstat has come to an end. | The company announced it has concluded ...
A new light-sensitive eye injection has successfully triggered visual signals in patients with severe retinal damage.
Saffie Sandford was born with Leber's Congenital Amaurosis and "missed out on a lot" due to difficulties seeing in any ...
GMA Network on MSN
Low genetic diversity puts Philippine eagle at risk of disease, breeding issues - study
The Philippine eagle has been identified as vulnerable to various threats as modern deforestation has intensified its decline ...
VisiFlora Ingredients, Gut-Eye LPS Formula, Lutein, Saffron, Bilberry, Pricing, and 60-Day Guarantee Explained for 2026 ...
Six-Month Clinical Data Demonstrate Restoration of Cone-Mediated Vision in Pediatric LCA5 Patients, with Sensitivity Improvements Reaching Normal ...
Jenna Cotromano shares how a Huntington’s disease diagnosis at 18 changed her life and why she now uses social media to ...
Cryo-EM imaging shows how cells assemble key microtubule proteins, helping explain rare genetic disorders linked to seizures, ...
A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma.
Thousands of times per year, a family's moment of joy turns to unexpected grief. A seemingly healthy infant stops smiling or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results